Kim 2015a.
Methods | A cohort study of methylphenidate use for 12 weeks | |
Participants | Number of participants screened: not stated Number of participants included: 86 Number of participants followed up: 37 Number of withdrawals: 49 Diagnosis of ADHD: DSM‐IV (subtype: inattentive, hyperactive‐impulsive or both) Age: mean 8 IQ: > 70 Sex: 34 males, 3 females Methylphenidate‐naïve: 2‐month washout period prior to study Ethnicity: not stated Country: Korea Comorbidity: none Comedication: none Sociodemographics: none Inclusion criteria
Exclusion criteria
|
|
Interventions | Methylphenidate type: immediate release or extended release Mean methylphenidate dosage: 22.23 (SD 8.93) mg/0.70 (SD 0.20) mg/kg Administration schedule: not stated Duration of intervention: 12 weeks Treatment compliance: 43% completed 12 week programme |
|
Outcomes |
Non‐serious adverse events: All participants were evaluated for adverse events during each visit, and an interview with their care providers was conducted |
|
Notes | Sample calculation: no Ethics approval: study approved by Institutional Review Board of Guro Hospital, Korea University Medical Center Funding/vested interests: financial support from Jun Sang‐Bae Child and Adolescent Psychiatry Research Grant from the Korean Foundation of Neuropsychiatric Research Key conclusions of the study authors: HF and RMSSD suggested that parasympathetic dominance in ADHD can be changed by methylphenidate treatment Exclusion of methylphenidate non‐responders/children who have previously experienced adverse events on methylphenidate: not stated Supplemental information requested twice from the study authors in May and June 2016 with no reply |